A role for ERG ubiquitination in prostate cancer cells was also demonstrated by Wang et al. who showed that the enzyme USP9X, which is highly expressed in ERG-positive prostate tumours, mediates ERG deubiquitination and thus its stabilization [111]. The gene discussed is USP9X; the disease is prostate carcinoma.